Lisa Marshall
Since 2017, researchers at the Center for Health & Neuroscience, Genes & Environment (CUChange) have been using a mobile van, a.k.a. the Cannavan, to study the real-time impacts of cannabis. In recognition of Cannabis Awareness Month, here's a look at what they've learned.
An analysis of DNA from two million people shows that that the same genetic architecture that underlies things like depression, ADHD and substance abuse also boosts risk of a host of physical illnesses.
A CU Boulder-led team has developed a suite of new therapies aimed at reversing osteoarthritis in a single injection. With animal studies showing promise and funding from the Advanced Research Projects Agency for Health extended, the team could be ready for human trials by 2028.
Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects or muscle wasting. The findings could lead to new weight loss therapies with fewer side effects.
A CU Boulder lab is exploring how age-related hearing loss rewires the brain—and whether hearing aids can undo the damage.
Supported by an up to $25 million federal award, a dream team of experts is working to develop the world’s first off-the-shelf engineered liver tissue.
In honor of Women's History Month, Marie Ranjbar, professor of women and gender studies, discusses the long history of feminist activism in Iran and how the ongoing war is impacting people on the ground.
An analysis of more than 20,000 power plants across 92 democratic countries found that in nations with more political incivility, power plants emit more carbon.
A new analysis of U.S. Immigration and Customs Enforcement arrests confirms that ICE tactics have changed since Trump’s first term, with more arrests made at workplaces and schools and in Democratic strongholds like Colorado.
Toxic protein clusters known as tau aggregates underlie dozens of neurodegenerative diseases, or "tauopathies." New research illuminates why they form and spread and how to stop them.